Sign inGet started

Thomas Thomas T.

Insider CIK 1689819 · OPNT Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
OPNT OPIANT PHARMACEUTICALS, IN D To issuer deriv2023-03-022023-03-032,500— $00SEC↗
OPNT OPIANT PHARMACEUTICALS, IN D To issuer deriv2023-03-022023-03-032,500— $00SEC↗
OPNT OPIANT PHARMACEUTICALS, IN D To issuer deriv2023-03-022023-03-032,500— $00SEC↗
OPNT OPIANT PHARMACEUTICALS, IN D To issuer deriv2023-03-022023-03-032,500— $00SEC↗
OPNT OPIANT PHARMACEUTICALS, IN D To issuer2023-03-022023-03-0310,375$20.00 $207.5K2,000SEC↗
OPNT OPIANT PHARMACEUTICALS, IN D To issuer2023-03-022023-03-032,000$20.00 $40.0K0SEC↗
OPNT OPIANT PHARMACEUTICALS, IN A Award2022-06-142022-06-142,000— $012,375SEC↗
OPNT OPIANT PHARMACEUTICALS, IN M Exercise deriv2021-09-222021-09-231,834— $00SEC↗
OPNT OPIANT PHARMACEUTICALS, IN S Sale2021-09-222021-09-23735$25.02 $18.4K10,375SEC↗
OPNT OPIANT PHARMACEUTICALS, IN M Exercise2021-09-222021-09-231,834$10.00 $18.3K11,110SEC↗
OPNT OPIANT PHARMACEUTICALS, IN M Exercise deriv2021-09-212021-09-232,000— $01,834SEC↗
OPNT OPIANT PHARMACEUTICALS, IN S Sale2021-09-212021-09-23771$24.12 $18.6K9,276SEC↗
OPNT OPIANT PHARMACEUTICALS, IN S Sale2021-09-212021-09-2360$24.07 $1.4K10,047SEC↗
OPNT OPIANT PHARMACEUTICALS, IN M Exercise2021-09-212021-09-232,000$10.00 $20.0K10,107SEC↗
OPNT OPIANT PHARMACEUTICALS, IN M Exercise deriv2021-09-142021-09-161,500— $03,834SEC↗
OPNT OPIANT PHARMACEUTICALS, IN M Exercise deriv2021-09-142021-09-161,500— $05,334SEC↗
OPNT OPIANT PHARMACEUTICALS, IN M Exercise deriv2021-09-142021-09-1625— $06,834SEC↗
OPNT OPIANT PHARMACEUTICALS, IN S Sale2021-09-142021-09-16792$19.06 $15.1K7,371SEC↗
OPNT OPIANT PHARMACEUTICALS, IN M Exercise2021-09-142021-09-161,500$10.00 $15.0K8,163SEC↗
OPNT OPIANT PHARMACEUTICALS, IN M Exercise2021-09-142021-09-1625$10.00 $2506,678SEC↗
OPNT OPIANT PHARMACEUTICALS, IN M Exercise2021-09-142021-09-161,500$10.00 $15.0K8,871SEC↗
OPNT OPIANT PHARMACEUTICALS, IN S Sale2021-09-142021-09-16764$19.70 $15.1K8,107SEC↗
OPNT OPIANT PHARMACEUTICALS, IN S Sale2021-09-142021-09-1615$18.95 $2846,663SEC↗
OPNT OPIANT PHARMACEUTICALS, IN M Exercise deriv2021-09-072021-09-091,475— $06,859SEC↗
OPNT OPIANT PHARMACEUTICALS, IN S Sale2021-09-072021-09-09822$18.00 $14.8K6,653SEC↗
OPNT OPIANT PHARMACEUTICALS, IN M Exercise2021-09-072021-09-091,475$10.00 $14.8K7,475SEC↗
OPNT OPIANT PHARMACEUTICALS, IN S Sale2021-08-192021-08-20600$16.20 $9.7K6,400SEC↗
OPNT OPIANT PHARMACEUTICALS, IN S Sale2021-08-192021-08-20400$16.25 $6.5K6,000SEC↗
OPNT OPIANT PHARMACEUTICALS, IN A Award deriv2021-06-152021-06-162,500— $02,500SEC↗
OPNT OPIANT PHARMACEUTICALS, IN A Award2021-06-152021-06-162,000— $07,000SEC↗
OPNT OPIANT PHARMACEUTICALS, IN P Buy2020-09-042020-09-08500$8.05 $4.0K5,000SEC↗
OPNT OPIANT PHARMACEUTICALS, IN P Buy2020-09-032020-09-082,500$8.40 $21.0K4,500SEC↗
OPNT OPIANT PHARMACEUTICALS, IN A Award deriv2020-06-152020-06-152,500— $02,500SEC↗
OPNT OPIANT PHARMACEUTICALS, IN A Award2020-06-152020-06-152,000— $02,000SEC↗
OPNT OPIANT PHARMACEUTICALS, IN A Award deriv2019-06-122019-06-132,500— $02,500SEC↗
OPNT OPIANT PHARMACEUTICALS, IN A Award deriv2018-06-132018-06-142,500— $02,500SEC↗
OPNT OPIANT PHARMACEUTICALS, IN S Sale2018-05-182018-05-18500$16.50 $8.3K0SEC↗
OPNT OPIANT PHARMACEUTICALS, IN S Sale2018-05-172018-05-18500$16.40 $8.2K1,500SEC↗
OPNT OPIANT PHARMACEUTICALS, IN S Sale2018-05-172018-05-18500$16.51 $8.3K1,000SEC↗
OPNT OPIANT PHARMACEUTICALS, IN S Sale2018-05-172018-05-18500$16.50 $8.3K500SEC↗
OPNT OPIANT PHARMACEUTICALS, IN S Sale2018-05-162018-05-18500$16.41 $8.2K2,263SEC↗
OPNT OPIANT PHARMACEUTICALS, IN S Sale2018-05-162018-05-18263$16.17 $4.3K2,000SEC↗
OPNT OPIANT PHARMACEUTICALS, IN S Sale2018-05-152018-05-15800$17.53 $14.0K2,763SEC↗
OPNT OPIANT PHARMACEUTICALS, IN S Sale2018-05-142018-05-153,500$18.54 $64.9K3,563SEC↗
OPNT OPIANT PHARMACEUTICALS, IN M Exercise deriv2018-05-112018-05-1515,000— $08,334SEC↗
OPNT OPIANT PHARMACEUTICALS, IN M Exercise2018-05-112018-05-157,063$10.00 $70.6K7,063SEC↗
OPNT OPIANT PHARMACEUTICALS, IN A Award deriv2017-08-292017-08-2911,667— $023,334SEC↗
OPNT OPIANT PHARMACEUTICALS, IN A Award deriv2016-12-132016-12-1511,667— $011,667SEC↗